Surgery and risks of transcatheter aortic valve replacement (TAVR) in Low Surgical Risk patients with aortic stenosis: Surgery and risks of transcatheter aortic valve replacement (TAVR) in Low Surgical Risk patients with aortic stenosis

Abdülkadir Çakmak

doi:10.22399/ijcesen.616

Authors

Abdülkadir Çakmak Yazar

DOI:

https://doi.org/10.22399/ijcesen.616

Keywords:

TAVR, Aortic Valve Replacement, Aortic Stenosis, Cardiology

Abstract

Transcatheter aortic valve replacement (TAVR) has been shown to be a valid alternative to surgical aortic valve replacement (SAVR) in high operative risk patients with severe aortic stenosis (AS). Evidence on the benefits and harms of TAVR in patients at low risk of surgery, however, is still scarce. In this study, we planned to review the literature on all aspects of transcatheter aortic valve replacement (TAVR) as a newly introduced method. In our review, TAVR was found to be safe in low-risk patients with symptomatic severe aortic stenosis in terms of low procedural complication rates, short hospital stays, zero mortality and risk of stroke that may leave 3 permanent sequelae. TAVR, both TAVR and SAVR carry similar stroke risks for intermediate-risk patients, suggesting that no procedure is inherently safer. Healthcare providers should take this into account when counselling individual patients, considering the benefits and disadvantages of each procedure. The present study focusses specifically on low-risk individuals, so the results for the intermediate-risk patients who may come before us may not be universally applicable.

References

Dangas, G. D., Tijssen, J. G., Wöhrle, J., Søndergaard, L., Gilard, M., Möllmann, H., ... & Windecker, S. (2020). A controlled trial of rivaroxaban after transcatheter aortic-valve replacement. New England journal of medicine, 382(2), 120-129.

Lou, Y., Gao, Y., Yu, Y., Li, Y., Xi, Z., Swe, K. N. C., ... & Liu, W. (2020). Efficacy and safety of transcatheter vs. surgical aortic valve replacement in low-to-intermediate-risk patients: a meta-analysis. Frontiers in Cardiovascular Medicine, 7, 590975. https://doi.org/10.3389/fcvm.2020.590975

Carroll, J. D., Mack, M. J., Vemulapalli, S., Herrmann, H. C., Gleason, T. G., Hanzel, G., ... & Bavaria, J. E. (2020). STS-ACC TVT registry of transcatheter aortic valve replacement. Journal of the American College of Cardiology, 76(21), 2492-2516. DOI: 10.1016/j.jacc.2020.09.595

Thourani, V. H., Edelman, J. J., Holmes, S. D., Nguyen, T. C., Carroll, J., Mack, M. J., ... & Ad, N. (2021). The International Society for Minimally Invasive Cardiothoracic Surgery expert consensus statement on transcatheter and surgical aortic valve replacement in low-and intermediate-risk patients: a meta-analysis of randomized and propensity-matched studies. Innovations, 16(1), 3-16. https://doi.org/10.1177/1556984520978316

Mc Morrow, R., Kriza, C., Urban, P., Amenta, V., Amaro, J. A. B., Panidis, D., ... & Griesinger, C. B. (2020). Assessing the safety and efficacy of TAVR compared to SAVR in low-to-intermediate surgical risk patients with aortic valve stenosis: An overview of reviews. International journal of cardiology, 314, 43-53. DOI: 10.1016/j.ijcard.2020.04.022

Landes, U., Webb, J. G., De Backer, O., Sondergaard, L., Abdel-Wahab, M., Crusius, L., ... & Barbanti, M. (2020). Repeat transcatheter aortic valve replacement for transcatheter prosthesis dysfunction. Journal of the American College of Cardiology, 75(16), 1882-1893. DOI: 10.1016/j.jacc.2020.02.051

Van Mieghem, N. M., Deeb, G. M., Søndergaard, L., Grube, E., Windecker, S., Gada, H., ... & Nathan, S. (2022). Self-expanding transcatheter vs surgical aortic valve replacement in intermediate-risk patients: 5-year outcomes of the SURTAVI randomized clinical trial. JAMA cardiology, 7(10), 1000-1008.

Kapadia, S. R., Makkar, R., Leon, M., Abdel-Wahab, M., Waggoner, T., Massberg, S., ... & Linke, A. (2022). Cerebral embolic protection during transcatheter aortic-valve replacement. New England Journal of Medicine, 387(14), 1253-1263. DOI: 10.1056/NEJMoa2204961

Winter, M. P., Bartko, P., Hofer, F., Zbiral, M., Burger, A., Ghanim, B., ... & Goliasch, G. (2020). Evolution of outcome and complications in TAVR: a meta-analysis of observational and randomized studies. Scientific reports, 10(1), 15568.

Jørgensen, T. H., Thyregod, H. G. H., Ihlemann, N., Nissen, H., Petursson, P., Kjeldsen, B. J., ... & Søndergaard, L. (2021). Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement. European heart journal, 42(30), 2912-2919. DOI: 10.1093/eurheartj/ehab375

Kowalówka, A. R., Kowalewski, M., Wańha, W., Kołodziejczak, M., Mariani, S., Li, T., ... & Deja, M. (2022). Surgical and transcatheter aortic valve replacement for severe aortic stenosis in low-risk elective patients: Analysis of the Aortic Valve Replacement in Elective Patients From the Aortic Valve Multicenter Registry. The Journal of Thoracic and Cardiovascular Surgery. DOI: 10.1016/j.jtcvs.2022.10.026

Overtchouk, P., Piazza, N., Granada, J., Soliman, O.Prendergast, B., & Modine, T. (2020). Advances in transcatheter mitral and tricuspid therapies. BMC cardiovascular disorders, 20, 1-10. https://doi.org/10.1186/s12872-019-01312-3

Rudzinski, P. N., Leipsic, J. A., Schoepf, U. J., Dudek, D., Schwarz, F., Andreas, M., ... & Bayer, R. R. (2022). CT in transcatheter-delivered treatment of valvular heart disease. Radiology, 304(1), 4-17. DOI: 10.1148/radiol.210567

de Siqueira, D. A. A., de Oliveira Ramos, A. I., & Feres,

Ryffel, C., Praz, F., Berto, M. B., de Marchi, S., Brugger, N., Pilgrim, T., ... & Gräni, C. (2024). Multimodality Imaging in the Management of Tricuspid Valve Regurgitation. Echocardiography, 41(10), e15960.

Martinsson, A., Rasalingam, R., & Jeppsson, A. (2024). Stable incidence and outcomes for patients with incident aortic stenosis: how can we translate excellent trial data into improved clinical outcomes in the population? European Heart Journal, 45(21), 1887-1889. DOI: 10.1093/eurheartj/ehae078

Gaede, L., Blumenstein, J., Eckel, C., Grothusen, C., Tiyerili, V., Sötemann, D., ... & Moellmann, H. (2022). Transcatheter-based aortic valve replacement vs. isolated surgical aortic valve replacement in 2020. Clinical Research in Cardiology, 111(8), 924-933. DOI: 10.1007/s00392-022-02006-1

Shrivastava, S., Shrivastava, S., Mumtaz, K., & Mostafa, J. A. (2022). Evolving indications of transcatheter aortic valve replacement compared to surgical valve replacement: a review of the current literature. Cureus. 14(3):e23364. doi: 10.7759/cureus.23364

Muneretto, C., Di Bacco, L., Di Eusanio, M., Folliguet, T., Rosati, F., D’Alonzo, M., ... & Fischlein, T. (2023). Sutureless and Rapid Deployment vs. Transcatheter Valves for Aortic Stenosis in Low-Risk Patients: Mid-Term Results. Journal of Clinical Medicine, 12(12), 4045. DOI: 10.3390/jcm12124045

Makkar, R. R., Thourani, V. H., Mack, M. J., Kodali, S. K., Kapadia, S., Webb, J. G., ... & Leon, M. B. (2020). Five-year outcomes of transcatheter or surgical aortic-valve replacement. New England Journal of Medicine, 382(9), 799-809. DOI: 10.1056/NEJMoa1910555

Mack, M. J., Leon, M. B., Thourani, V. H., Pibarot, P., Hahn, R. T., Genereux, P., ... & Makkar, R. (2023). Transcatheter aortic-valve replacement in low-risk patients at five years. New England Journal of Medicine, 389(21), 1949-1960. DOI: 10.1056/NEJMoa2307447

Mesnier, J., Panagides, V., Nuche, J., & Rodes-Cabau, J. (2022). Evolving indications of transcatheter aortic valve replacement—where are we now, and where are we going. Journal of Clinical Medicine, 11(11), 3090. DOI: 10.3390/jcm11113090

Tarantini, G., Sathananthan, J., Fabris, T., Landes, U., Bapat, V. N., Khan, J. M., ... & Tang, G. H. (2022). Transcatheter aortic valve replacement in failed transcatheter bioprosthetic valves. Cardiovascular Interventions, 15(18), 1777-1793.

Del Val, D., Panagides, V., Mestres, C. A., Miró, J. M., & Rodés-Cabau, J. (2023). Infective endocarditis after transcatheter aortic valve replacement: JACC state-of-the-art review. Journal of the American College of Cardiology, 81(4), 394-412. DOI: 10.1016/j.jacc.2022.11.028

Wang, X., Vaduganathan, M., Claggett, B. L., Hegde, S. M., Pabon, M., Kulac, I. J., ... & Lam, C. S. (2023). Sex differences in characteristics, outcomes, and treatment response with dapagliflozin across the range of ejection fraction in patients with heart failure: insights from DAPA-HF and DELIVER. Circulation, 147(8), 624-634.

Yan, J., Liu, M., Yang, D., Zhang, Y., & An, F. (2024). Efficacy and safety of omega-3 fatty acids in the prevention of cardiovascular disease: a systematic review and meta-analysis. Cardiovascular Drugs and Therapy. 38(4):799-817. doi: 10.1007/s10557-022-07379-z

Schupp, T., Thiele, H., Rassaf, T., Abbas Mahabadi, A., Lehmann, R., Eitel, I., ... & Akin, I. (2024). Prognostic impact of admission time in infarct-related cardiogenic shock: an ECLS-SHOCK substudy. Cardiovascular Interventions, 17(19), 2228-2239.

Jaber, W. A., Gonsalves, C. F., Stortecky, S., Horr, S., Pappas, O., Gandhi, R. T., ... & Gibson, C. M. (2024). Large-bore Mechanical Thrombectomy Versus Catheter-directed Thrombolysis in the Management of Intermediate-risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled Trial. Circulation. doi: 10.1161/CIRCULATIONAHA.124.072364

Dimitriadis, K., Pyrpyris, N., Aznaouridis, K., Adamopoulou, E., Soulaidopoulos, S., Beneki, E., ... & Tsioufis, K. (2024). Transcatheter Structural Heart Disease Interventions and Concomitant Left Atrial Appendage Occlusion: A State-of-the-Art Review. Canadian Journal of Cardiology. S0828-282X(24)00935-8. doi: 10.1016/j.cjca.2024.08.282

de Oliveira Sá, M. P. B., Cavalcanti, L. R. P., Perazzo, Á. M., Gomes, R. A., Clavel, M. A., Pibarot, P., ... & Lima, R. C. (2020). Calcific aortic valve stenosis and atherosclerotic calcification. Current atherosclerosis reports, 22, 1-6.

Lindman, B. R., Sukul, D., Dweck, M. R., Madhavan, M. V., Arsenault, B. J., Coylewright, M., ... & Pibarot, P. (2021). Evaluating medical therapy for calcific aortic stenosis: JACC state-of-the-art review. Journal of the American College of Cardiology, 78(23), 2354-2376.

Mittal, T. K. & Marcus, N. (2021). Imaging diagnosis of aortic stenosis. Clinical Radiology. 76(1):3-14. doi: 10.1016/j.crad.2020.04.008

Junco-Vicente, A., Solache-Berrocal, G., del Río-García, Á., Rolle-Sóñora, V., Areces, S., Morís, C., ... & Thiene, G., Rizzo, S., & Basso, C. (2024). Bicuspid aortic valve: The most frequent and not so benign congenital heart disease. Cardiovascular Pathology. 9:989539. doi: 10.3389/fcvm.2022.989539

Idil Soylu, A., Avcıoglu, U., Uzunkaya, F., & Soylu, K. (2021). Evaluation of mesenteric artery disease in patients with severe aortic valve stenosis. Journal of Investigative Medicine, 69(3), 719-723.

Kato, N., Tabata, M., Noguchi, M., Ito, J., Obunai, K., Watanabe, H., ... & OCEAN‐TAVI investigators. (2024). Transcatheter aortic valve implantation for combined aortic and mitral stenoses: Insights from the OCEAN‐TAVI Registry. ESC Heart Failure. doi: 10.1002/ehf2.15030

Iung, B., Pierard, L., Magne, J., Messika-Zeitoun, D., Pibarot, P., & Baumgartner, H. (2023). Great debate: all patients with asymptomatic severe aortic stenosis need valve replacement. European Heart Journal, 44(33), 3136-3148.

Pepe, M., Larosa, C., Rosa, I., Biondi-Zoccai, G., Nestola, P. L., Di Cillo, O., ... & Favale, S. (2020). Degenerative severe aortic stenosis and concomitant coronary artery disease: what is changing in the era of the “Transcatheter Revolution”?. Current Atherosclerosis Reports, 22, 1-12.

Senthanu, I. G. A. I., & Gayatri, D. A. A. M. (2024). Long-Term Comparative Effectiveness of Transcatheter Aortic Valve Replacement (TAVR) Versus Surgical Aortic Valve Replacement (SAVR) in High-Risk Aortic Stenosis Patients: A Meta-Analysis. Open Access Indonesian Journal of Medical Reviews, 4(3), 645-655.

Windecker, S., Okuno, T., Unbehaun, A., Mack, M., Kapadia, S., & Falk, V. (2022). Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation?. European heart journal, 43(29), 2729-2750.

Androshchuk, V., Patterson, T., & Redwood, S. R. (2023). Management of coronary artery disease in patients with aortic stenosis. Heart. 109(4):322-329. doi: 10.1136/heartjnl-2022-321605

Spears, J., Al-Saiegh, Y., Goldberg, D., Manthey, S., & Goldberg, S. (2020). TAVR: a review of current practices and considerations in low‐risk patients. Journal of interventional cardiology, 2020(1), 2582938. doi: 10.1155/2020/2582938.

Llerena-Velastegui, J., Navarrete-Cadena, C., Delgado-Quijano, F., Trujillo-Delgado, M., Aguayo-Zambrano, J., Villacis-Lopez, C., ... & Vega-Zapata, J. (2024). Frequency of stroke in Intermediate-Risk patients in the long-term undergoing TAVR vs SAVR: a systematic review and Meta-analysis. Current Problems in Cardiology, 49(1), 102099.

Patel, K. V., Omar, W., Gonzalez, P. E., Jessen, M. E., Huffman, L., Kumbhani, D. J., & Bavry, A. A. (2020). Expansion of TAVR into low-risk patients and who to consider for SAVR. Cardiology and therapy, 9, 377-394. doi: 10.1007/s40119-020-00198-z.

Azraai, M., Gao, L., & Ajani, A. E. (2020). Cost-effectiveness of transcatheter aortic valve intervention (TAVI) compared to surgical aortic valve replacement (SAVR) in low-to intermediate-surgical-risk patients. Cardiovascular Revascularization Medicine. 21(9):1164-1168. doi: 10.1016/j.carrev.2020.01.009.

Okuno, T., Demirel, C., Tomii, D., Erdoes, G., Heg, D., Lanz, J., ... & Pilgrim, T. (2022). Risk and timing of noncardiac surgery after transcatheter aortic valve implantation. JAMA Network Open, 5(7), e2220689-e2220689.

Delhomme, C., Urena, M., Zouaghi, O., Campelo-Parada, F., Ohlmann, P., Rioufol, G., ... & Himbert, D. (2023). Transcatheter aortic valve implantation using the SAPIEN 3 valve to treat aortic regurgitation: The French multicentre S3AR study. Archives of cardiovascular diseases, 116(2), 98-105. DOI: 10.1016/j.acvd.2022.12.003

Rodríguez, J. M. V., Bermúdez, E. P., Zamorano, J. L., Burgos, J. M., Díaz-Fernández, J. F., del Blanco, B. G., ... & Green, M. (2023). Cost-effectiveness of SAPIEN 3 transcatheter aortic valve implantation in low surgical mortality risk patients in Spain. mortality, 4, 5.

Kvaslerud, A. B., Santic, K., Hussain, A. I., Auensen, A., Fiane, A., Skulstad, H., ... & Broch, K. (2021). Outcomes in asymptomatic, severe aortic stenosis. PLoS One, 16(4), e0249610.

Costa, G. N. F., Cardoso, J. F. L., Oliveiros, B., Gonçalves, L., & Teixeira, R. (2023). Early surgical intervention versus conservative management of asymptomatic severe aortic stenosis: a systematic review and meta-analysis. Heart, 109(4), 314-321.

Jaiswal, V., Khan, N., Jaiswal, A., Dagar, M., Joshi, A., Huang, H., ... & Song, D. (2022). Early surgery vs conservative management among asymptomatic aortic stenosis: a systematic review and meta-analysis. IJC Heart & Vasculature, 43, 101125.

Clark, K. A., Chouairi, F., Kay, B., Reinhardt, S. W., Miller, P. E., Fuery, M., ... & Desai, N. R. (2022). Trends in transcatheter and surgical aortic valve replacement in the United States, 2008-2018. American Heart Journal, 243, 87-91.

Coylewright, M., Forrest, J. K., McCabe, J. M., & Nazif, T. M. (2020). TAVR in low-risk patients: FDA approval, the new NCD, and shared decision-making. Journal of the American College of Cardiology, 75(10), 1208-1211.

Johnston, D. R., Mahboubi, R., Soltesz, E. G., & Artis…, A. S. (2023). Redefining “low risk”: outcomes of surgical aortic valve replacement in low-risk patients in the transcatheter aortic valve replacement era. … Cardiovascular Surgery. 165(2):591-604.e3. doi: 10.1016/j.jtcvs.2021.01.145

Forrest, J. K., Ramlawi, B., Deeb, G. M., Zahr, F., Song, H. K., Kleiman, N. S., ... & Reardon, M. J. (2021). Transcatheter aortic valve replacement in low-risk patients with bicuspid aortic valve stenosis. JAMA cardiology, 6(1), 50-57.

Williams, M. R., Jilaihawi, H., Makkar, R., O’Neill, W. W., Guyton, R., Malaisrie, S. C., ... & Webb, J. G. (2022). The PARTNER 3 bicuspid registry for transcatheter aortic valve replacement in low-surgical-risk patients. Cardiovascular Interventions, 15(5), 523-532.

Zhou, J. Y., Liew, D., Duffy, S. J., Walton, A., Htun, N., & Stub, D. (2021). Cost-effectiveness of transcatheter versus surgical aortic valve replacement in low-risk patients with severe aortic stenosis. Heart, Lung and Circulation, 30(4), 547-554.

Fernández‐Fernández, I., Castro‐Sánchez, E., & Blanco‐Mavillard, I. (2024). Determinants of the optimal selection of vascular access devices: A systematic review underpinned by the COM‐B behavioural model. Journal of advanced nursing. doi: 10.1111/jan.16202

Comber, E. R., Keogh, S., Nguyen, L. N., Byrnes, J., & Ullman, A. J. (2024). Implementation frameworks, strategies and outcomes in optimizing central venous access device practice in paediatrics: A scoping review. Journal of Advanced Nursing. doi: 10.1111/jan.16268.

Team, V., Bouguettaya, A., Qiu, Y., Turnour, L., Banaszak‐Holl, J. C., Weller, C. D., ... & Teede, H. (2024). Nurses' experiences of hospital‐acquired pressure injury prevention in acute healthcare services in Victoria, Australia: A qualitative study using the Theoretical Domains Framework. International Wound Journal, 21(7), e14956.

Caminiti, R., Ielasi, A., Vetta, G., Parlavecchio, A., Della Rocca, D. G., Glauber, M., ... & Micari, A. (2024). Long-Term Results Following Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients with Severe Aortic Stenosis: A Systematic Review and Meta-Analysis of Randomized Trials. The American Journal of Cardiology. 230;6-13. doi: 10.1016/j.amjcard.2024.08.014

Malvindi, P. G., Luthra, S., Giritharan, S., Kowalewski, M., & Ohri, S. (2021). Long-term survival after surgical aortic valve replacement in patients aged 80 years and over. European Journal of Cardio-Thoracic Surgery, 60(3), 671-678.

Steffen, J., Reißig, N., Andreae, D., Beckmann, M., Haum, M., Fischer, J., ... & Deseive, S. (2022). TAVI in patients with low-flow low-gradient aortic stenosis–short-term and long-term outcomes. Clinical Research in Cardiology, 111(12), 1325-1335.

Say, A., & Çakır, D. (2021). The effect of delayed medical care process on patients in the Covid-19 pandemic. EJONS International Journal on Mathematic, Engineering and Natural Sciences, 17(1), 1-9.

Mahajan, S., Gupta, R., Malik, A. H., Mahajan, P., Aedma, S. K., Aronow, W. S., ... & Lakkireddy, D. R. (2021). Predictors of permanent pacemaker insertion after TAVR: a systematic review and updated meta‐analysis. Journal of cardiovascular electrophysiology, 32(5), 1411-1420.

Biancari, F., Pykäri, J., Savontaus, M., Laine, M., Husso, A., Virtanen, M., ... & Airaksinen, J. (2021). Early and late pace‐maker implantation after transcatheter and surgical aortic valve replacement. Catheterization and Cardiovascular Interventions, 97(4), E560-E568.

Sá, M. P., Jacquemyn, X., Sun, T., Van den Eynde, J., Tasoudis, P., Erten, O., ... & Ramlawi, B. (2022). Late outcomes of permanent pacemaker implantation after TAVR: meta-analysis of reconstructed time-to-event data. Journal of the Society for Cardiovascular Angiography & Interventions, 1(5), 100434.

Sakurai, Y., Mehaffey, J. H., Kuno, T., Yokoyama, Y., Takagi, H., Denning, D. A., ... & Badhwar, V. (2024). The impact of permanent pacemaker implantation on long-term survival after cardiac surgery: A systematic review and meta-analysis. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2024.04.024

Hokken, T. W., Muhemin, M., Okuno, T., Veulemans, V., Lopes, B. B., Beneduce, A., ... & Van Mieghem, N. M. (2022). Impact of membranous septum length on pacemaker need with different transcatheter aortic valve replacement systems: the INTERSECT registry. Journal of cardiovascular computed tomography, 16(6), 524-530.

Alperi, A., Voisine, P., Kalavrouziotis, D., Dumont, E., Dagenais, F., Perron, J., ... & Rodes-Cabau, J. (2021). Aortic valve replacement in low-risk patients with severe aortic stenosis outside randomized trials. Journal of the American College of Cardiology, 77(2), 111-123.

Yerasi, C., Rogers, T., Forrestal, B. J., Case, B. C., Khan, J. M., Ben-Dor, I., ... & Waksman, R. (2021). Transcatheter versus surgical aortic valve replacement in young, low-risk patients with severe aortic stenosis. Cardiovascular Interventions, 14(11), 1169-1180.

Tam, D. Y., Azizi, P. M., Fremes, S. E., Chikwe, J., Gaudino, M., & Wijeysundera, H. C. (2021). The cost-effectiveness of transcatheter aortic valve replacement in low surgical risk patients with severe aortic stenosis. European Heart Journal-Quality of Care and Clinical Outcomes, 7(6), 556-563. doi: 10.1093/ehjqcco/qcaa058

Surgery and risks of transcatheter aortic valve replacement (TAVR) in Low Surgical Risk patients with aortic stenosis